Home/Pipeline/RejuverSen Platform

RejuverSen Platform

Fibrosis (IPF, CKD)

DiscoveryPre-clinical models; 5 novel targets identified

Key Facts

Indication
Fibrosis (IPF, CKD)
Phase
Discovery
Status
Pre-clinical models; 5 novel targets identified
Company

About Centenara Labs

Centenara Labs is a pioneering longevity-focused biotech that builds and invests in a diversified portfolio of companies targeting geriatric diseases through the lens of aging biology. Its strategy involves de-risking early scientific discoveries by providing a platform of experienced drug developers, business leaders, and capital. With a pipeline built around the hallmarks of aging, the company has progressed two ophthalmology programs into the clinic and is advancing several pre-clinical assets in fibrosis, cancer, and sarcopenia, aiming to create optimal exit scenarios to fund new ventures.

View full company profile